Leo Pharm Drug Patent Portfolio
Leo Pharm's Family Patents
Clinical Trials
Recent Clinical Trials by Leo Pharm:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum | LEO Pharma | NA |
RECRUITING
(Sep 1, 2026)
| PHASE3 |
| A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus | LEO Pharma | NA |
RECRUITING
(Sep 1, 2026)
| PHASE3 |
| A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis | LEO Pharma | NA |
RECRUITING
(Aug 1, 2026)
| PHASE2 |
| Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema | LEO Pharma | NA |
COMPLETED
(Apr 1, 2026)
| PHASE3 |
| Investigation of Flare and Remission in Subjects With Atopic Dermatitis | LEO Pharma | NA |
WITHDRAWN
(Jul, 2019)
| PHASE4 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List